{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:48:49Z","timestamp":1778878129552,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Innovation and Entrepreneurship Training Program of Shenyang Pharmaceutical University","award":["201710163000006"],"award-info":[{"award-number":["201710163000006"]}]},{"name":"Foundation of Liaoning Education Committee","award":["51120427"],"award-info":[{"award-number":["51120427"]}]},{"name":"Doctoral Starting up Foundation of Liaoning Science and Technology Department","award":["51120390"],"award-info":[{"award-number":["51120390"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11010-018-3414-9","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T17:50:19Z","timestamp":1531936219000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Silibinin ameliorates amylin-induced pancreatic \u03b2-cell apoptosis partly via upregulation of GLP-1R\/PKA pathway"],"prefix":"10.1007","volume":"452","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingsi","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ushiki-Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"issue":"Suppl 2","key":"3414_CR1","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.2337\/diabetes.54.suppl_2.S108","volume":"54","author":"MY Donath","year":"2005","unstructured":"Donath MY et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108\u2013S113","journal-title":"Diabetes"},{"key":"3414_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ajcn\/87.1.126","volume":"87","author":"NR Sahyoun","year":"2008","unstructured":"Sahyoun NR et al (2008) Dietary diabete glycemic index and glycemic load and the risk of type 2 diabetes in older adults. Am J Clin Nutr 87:126\u2013131","journal-title":"Am J Clin Nutr"},{"key":"3414_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2015.03.153","volume":"460","author":"J Janikiewicz","year":"2015","unstructured":"Janikiewicz J, Hanzelka K, Kozinski K, Kolczynska K, Dobrzyn A (2015) Islet beta-cell failure in type 2 diabetes\u2014within the network of toxic lipids. Biochem Biophys Res Commun 460:491\u2013496. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.153","journal-title":"Biochem Biophys Res Commun"},{"key":"3414_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/er.2007-0037","volume":"29","author":"L Haataja","year":"2008","unstructured":"Haataja L, Gurlo T, Huang CJ, Butler PC (2008) Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 29:303\u2013316. \n                    https:\/\/doi.org\/10.1210\/er.2007-0037","journal-title":"Endocr Rev"},{"key":"3414_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark P, Andersson A, Westermark GT (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91:795\u2013826. \n                    https:\/\/doi.org\/10.1152\/physrev.00042.2009","journal-title":"Physiol Rev"},{"key":"3414_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00125-012-2802-z","volume":"56","author":"YJ Park","year":"2013","unstructured":"Park YJ et al (2013) The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation. Diabetologia 56:508\u2013519. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2802-z","journal-title":"Diabetologia"},{"key":"3414_CR7","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"CA Jurgens","year":"2011","unstructured":"Jurgens CA et al (2011) beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol 178:2632\u20132640. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.036","journal-title":"Am J Pathol"},{"key":"3414_CR8","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1021\/acs.biochem.6b00578","volume":"55","author":"P Velander","year":"2016","unstructured":"Velander P, Wu L, Ray WK, Helm RF, Xu B (2016) Amylin amyloid inhibition by flavonoid baicalein: key roles of its vicinal dihydroxyl groups of the catechol moiety. Biochemistry 55:4255\u20134258. \n                    https:\/\/doi.org\/10.1021\/acs.biochem.6b00578","journal-title":"Biochemistry"},{"key":"3414_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jinorgbio.2014.07.002","volume":"140","author":"L Ma","year":"2014","unstructured":"Ma L, Li X, Wang Y, Zheng W, Chen T (2014) Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction. J Inorg Biochem 140:143\u2013152. \n                    https:\/\/doi.org\/10.1016\/j.jinorgbio.2014.07.002","journal-title":"J Inorg Biochem"},{"key":"3414_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4239\/wjd.v7.i9.189","volume":"7","author":"XX Zhang","year":"2016","unstructured":"Zhang XX, Pan YH, Huang YM, Zhao HL (2016) Neuroendocrine hormone amylin in diabetes. World J Diabetes 7:189\u2013197. \n                    https:\/\/doi.org\/10.4239\/wjd.v7.i9.189","journal-title":"World J Diabetes"},{"key":"3414_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-160047","volume":"53","author":"N Verma","year":"2016","unstructured":"Verma N et al (2016) Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1beta synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and in diabetic HIP rats. J Alzheimer Dis 53:259\u2013272. \n                    https:\/\/doi.org\/10.3233\/JAD-160047","journal-title":"J Alzheimer Dis"},{"key":"3414_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2016.02.034","volume":"162","author":"EG Mietlicki-Baase","year":"2016","unstructured":"Mietlicki-Baase EG (2016) Amylin-mediated control of glycemia, energy balance, and cognition. Physiol Behav 162:130\u2013140. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2016.02.034","journal-title":"Physiol Behav"},{"key":"3414_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2013.00042","volume":"5","author":"W Fu","year":"2013","unstructured":"Fu W, Patel A, Jhamandas JH (2013) Amylin receptor: a common pathophysiological target in Alzheimer\u2019s disease and diabetes mellitus. Front Aging Neurosci 5:42. \n                    https:\/\/doi.org\/10.3389\/fnagi.2013.00042","journal-title":"Front Aging Neurosci"},{"key":"3414_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2015.00216","volume":"9","author":"TA Lutz","year":"2015","unstructured":"Lutz TA, Meyer U (2015) Amylin at the interface between metabolic and neurodegenerative disorders. Front Neurosci 9:216. \n                    https:\/\/doi.org\/10.3389\/fnins.2015.00216","journal-title":"Front Neurosci"},{"key":"3414_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","volume":"111","author":"B Akesson","year":"2003","unstructured":"Akesson B, Panagiotidis G, Westermark P, Lundquist I (2003) Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Regul Pept 111:55\u201360","journal-title":"Regul Pept"},{"key":"3414_CR16","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131\u20132157. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2007.03.054","journal-title":"Gastroenterology"},{"key":"3414_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409\u20131439. \n                    https:\/\/doi.org\/10.1152\/physrev.00034.2006","journal-title":"Physiol Rev"},{"key":"3414_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1210\/er.2007-0031","volume":"29","author":"M Salehi","year":"2008","unstructured":"Salehi M, Aulinger BA, D\u2019Alessio DA (2008) Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins. Endocr Rev 29:367\u2013379. \n                    https:\/\/doi.org\/10.1210\/er.2007-0031","journal-title":"Endocr Rev"},{"key":"3414_CR19","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1210\/en.2006-0153","volume":"148","author":"TP Vahl","year":"2007","unstructured":"Vahl TP et al (2007) Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148:4965\u20134973. \n                    https:\/\/doi.org\/10.1210\/en.2006-0153","journal-title":"Endocrinology"},{"key":"3414_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","volume":"21","author":"FA Duca","year":"2015","unstructured":"Duca FA et al (2015) Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med 21:506\u2013511. \n                    https:\/\/doi.org\/10.1038\/nm.3787","journal-title":"Nat Med"},{"key":"3414_CR21","doi-asserted-by":"publisher","first-page":"10728","DOI":"10.1074\/jbc.M900166200","volume":"284","author":"OG Chepurny","year":"2009","unstructured":"Chepurny OG et al (2009) Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2\u2032-O-Me-cAMP-AM. J Biol Chem 284:10728\u201310736. \n                    https:\/\/doi.org\/10.1074\/jbc.M900166200","journal-title":"J Biol Chem"},{"key":"3414_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/dmrr.580","volume":"22","author":"H Hashiguchi","year":"2006","unstructured":"Hashiguchi H et al (2006) Cyclic AMP\/cAMP-GEF pathway amplifies insulin exocytosis induced by Ca2+ and ATP in rat islet beta-cells. Diabetes\/Metab Res Rev 22:64\u201371. \n                    https:\/\/doi.org\/10.1002\/dmrr.580","journal-title":"Diabetes\/Metab Res Rev"},{"key":"3414_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","volume":"15","author":"AR Meloni","year":"2013","unstructured":"Meloni AR, DeYoung MB, Lowe C, Parkes DG (2013) GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence. Diabetes Obes Metab 15:15\u201327. \n                    https:\/\/doi.org\/10.1111\/j.1463-1326.2012.01663.x","journal-title":"Diabetes Obes Metab"},{"key":"3414_CR24","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.biocel.2004.04.011","volume":"36","author":"RA Lockshin","year":"2004","unstructured":"Lockshin RA, Zakeri Z (2004) Apoptosis, autophagy, and more. Int J Biochem Cell Biol 36:2405\u20132419. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2004.04.011","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 1","key":"3414_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3260001","volume":"326","author":"GM Cohen","year":"1997","unstructured":"Cohen GM (1997) Caspases: the executioners of apoptosis. The Biochem J 326(Pt 1):1\u201316","journal-title":"The Biochem J"},{"key":"3414_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bbrc.2013.01.109","volume":"432","author":"W Liu","year":"2013","unstructured":"Liu W et al (2013) Interference of silibinin with IGF-1R signalling pathways protects human epidermoid carcinoma A431 cells from UVB-induced apoptosis. Biochem Biophys Res Commun 432:314\u2013319. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2013.01.109","journal-title":"Biochem Biophys Res Commun"},{"key":"3414_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0962-8924(98)01273-2","volume":"8","author":"D Green","year":"1998","unstructured":"Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8:267\u2013271","journal-title":"Trends Cell Biol"},{"key":"3414_CR28","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1038\/s41598-018-24076-w","volume":"8","author":"CF Huang","year":"2018","unstructured":"Huang CF et al (2018) Low-dose tributyltin exposure induces an oxidative stress-triggered JNK-related pancreatic beta-cell apoptosis and a reversible hypoinsulinemic hyperglycemia in mice. Sci Rep 8:5734. \n                    https:\/\/doi.org\/10.1038\/s41598-018-24076-w","journal-title":"Sci Rep"},{"key":"3414_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.biopha.2018.01.128","volume":"102","author":"J Yang","year":"2018","unstructured":"Yang J et al (2018) Involvement of estrogen receptors in silibinin protection of pancreatic beta-cells from TNFalpha- or IL-1beta-induced cytotoxicity. Biomed Pharmacother 102:344\u2013353. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2018.01.128","journal-title":"Biomed Pharmacother"},{"key":"3414_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1053\/jhep.1996.v23.pm0008666328","volume":"23","author":"C Dehmlow","year":"1996","unstructured":"Dehmlow C, Erhard J, de Groot H (1996) Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 23:749\u2013754. \n                    https:\/\/doi.org\/10.1053\/jhep.1996.v23.pm0008666328","journal-title":"Hepatology"},{"key":"3414_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1254\/jphs.09315FP","volume":"113","author":"W Duan","year":"2010","unstructured":"Duan W et al (2010) Silibinin induced autophagic and apoptotic cell death in HT1080 cells through a reactive oxygen species pathway. J Pharmacol Sci 113:48\u201356","journal-title":"J Pharmacol Sci"},{"key":"3414_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopha.2017.02.018","volume":"89","author":"T Wang","year":"2017","unstructured":"Wang T et al (2017) The protective effects of silibinin in the treatment of streptozotocin-induced diabetic osteoporosis in rats. Biomed Pharmacother 89:681\u2013688. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2017.02.018","journal-title":"Biomed Pharmacother"},{"key":"3414_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/10286020.2012.657180","volume":"14","author":"Q Wang","year":"2012","unstructured":"Wang Q et al (2012) In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic beta-cell. J Asian Nat Prod Res 14:413\u2013423. \n                    https:\/\/doi.org\/10.1080\/10286020.2012.657180","journal-title":"J Asian Nat Prod Res"},{"key":"3414_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.physbeh.2017.07.023","volume":"179","author":"X Song","year":"2017","unstructured":"Song X et al (2017) Silibinin ameliorates anxiety\/depression-like behaviors in amyloid beta-treated rats by upregulating BDNF\/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav 179:487\u2013493. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2017.07.023","journal-title":"Physiol Behav"},{"key":"3414_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-018-2481-3","author":"X Song","year":"2018","unstructured":"Song X et al (2018) Estrogen receptors are involved in the neuroprotective effect of Silibinin in abeta1\u201342-treated rats. Neurochem Res. \n                    https:\/\/doi.org\/10.1007\/s11064-018-2481-3","journal-title":"Neurochem Res"},{"key":"3414_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s11064-016-2141-4","volume":"42","author":"X Song","year":"2017","unstructured":"Song X et al (2017) Silibinin ameliorates Abeta25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress. Neurochem Res 42:1073\u20131083. \n                    https:\/\/doi.org\/10.1007\/s11064-016-2141-4","journal-title":"Neurochem Res"},{"key":"3414_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/0-89603-062-8:1","volume":"1","author":"JH Waterborg","year":"1984","unstructured":"Waterborg JH, Matthews HR (1984) The lowry method for protein quantitation. Methods Mol Biol 1:1\u20133. \n                    https:\/\/doi.org\/10.1385\/0-89603-062-8:1","journal-title":"Methods Mol Biol"},{"key":"3414_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jcjd.2015.02.002","volume":"39","author":"OH Yu","year":"2015","unstructured":"Yu OH, Yin H, Azoulay L (2015) The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death. Can J Diabetes 39:383\u2013389. \n                    https:\/\/doi.org\/10.1016\/j.jcjd.2015.02.002","journal-title":"Can J Diabetes"},{"key":"3414_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1051\/medsci\/20143001018","volume":"30","author":"M Foretz","year":"2014","unstructured":"Foretz M, Viollet B (2014) New promises for metformin: advances in the understanding of its mechanisms of action. Med Sci 30:82\u201392. \n                    https:\/\/doi.org\/10.1051\/medsci\/20143001018","journal-title":"Med Sci"},{"key":"3414_CR40","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S et al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553\u20131562. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000159740.16984.3C","journal-title":"Neurology"},{"key":"3414_CR41","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","volume":"277","author":"M Sakono","year":"2010","unstructured":"Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277:1348\u20131358. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07568.x","journal-title":"FEBS J"},{"key":"3414_CR42","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-161192","author":"P Bharadwaj","year":"2017","unstructured":"Bharadwaj P et al (2017) The link between type 2 diabetes and neurodegeneration: roles for amyloid-beta, amylin, and tau proteins. J Alzheimer Dis. \n                    https:\/\/doi.org\/10.3233\/JAD-161192","journal-title":"J Alzheimer Dis"},{"key":"3414_CR43","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","volume":"31","author":"J Miklossy","year":"2010","unstructured":"Miklossy J et al (2010) Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 31:1503\u20131515. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.08.019","journal-title":"Neurobiol Aging"},{"key":"3414_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neuroscience.2014.02.022","volume":"277","author":"HY Cai","year":"2014","unstructured":"Cai HY et al (2014) Lixisenatide rescues spatial memory and synaptic plasticity from amyloid beta protein-induced impairments in rats. Neuroscience 277:6\u201313. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2014.02.022","journal-title":"Neuroscience"},{"key":"3414_CR45","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2174\/1871527311211080015","volume":"11","author":"F Yin","year":"2012","unstructured":"Yin F, Zhang Y, Guo L, Kong S, Liu J (2012) Geniposide regulates insulin-degrading enzyme expression to inhibit the cytotoxicity of Abeta1\u201342 in cortical neurons. CNS Neurol Disord Drug Targets 11:1045\u20131051","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3414_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/1567205054367892","volume":"2","author":"T Perry","year":"2005","unstructured":"Perry T, Greig NH (2005) Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer\u2019s disease. Curr Alzheimer Res 2:377\u2013385","journal-title":"Curr Alzheimer Res"},{"key":"3414_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2174\/1871527314666141229110156","volume":"14","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Xia Z, Liu J, Yin F (2015) Cell signaling mechanisms by which geniposide regulates insulin-degrading enzyme expression in primary cortical neurons. CNS Neurol Disord Drug Targets 14:370\u2013377","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3414_CR48","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","volume":"60","author":"A Gupta","year":"2011","unstructured":"Gupta A, Bisht B, Dey CS (2011) Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes. Neuropharmacology 60:910\u2013920. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.033","journal-title":"Neuropharmacology"},{"key":"3414_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","volume":"31","author":"AM Koenig","year":"2017","unstructured":"Koenig AM et al (2017) Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis Assoc Disord 31:107\u2013113. \n                    https:\/\/doi.org\/10.1097\/WAD.0000000000000202","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3414_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1421430","author":"B Chen","year":"2016","unstructured":"Chen B, Teng Y, Zhang X, Lv X, Yin Y (2016) Metformin alleviated abeta-induced apoptosis via the suppression of JNK MAPK signaling pathway in cultured hippocampal neurons. BioMed Res Int. \n                    https:\/\/doi.org\/10.1155\/2016\/1421430\n                    \n                   (2016)","journal-title":"BioMed Res Int"},{"key":"3414_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/JAD-141332","volume":"44","author":"KA DiTacchio","year":"2015","unstructured":"DiTacchio KA, Heinemann SF, Dziewczapolski G (2015) Metformin treatment alters memory function in a mouse model of Alzheimer\u2019s disease. J Alzheimer Dis 44:43\u201348. \n                    https:\/\/doi.org\/10.3233\/JAD-141332","journal-title":"J Alzheimer Dis"},{"key":"3414_CR52","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1007\/s12035-016-0085-y","volume":"54","author":"W Ahmad","year":"2017","unstructured":"Ahmad W, Ebert PR (2017) Metformin attenuates abeta pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. elegans model of Alzheimer\u2019s disease. Mol Neurobiol 54:5427\u20135439. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0085-y","journal-title":"Mol Neurobiol"},{"key":"3414_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","volume":"4","author":"B Yusta","year":"2006","unstructured":"Yusta B et al (2006) GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4:391\u2013406. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2006.10.001","journal-title":"Cell Metab"},{"key":"3414_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jmb.2012.01.048","volume":"421","author":"J Seeliger","year":"2012","unstructured":"Seeliger J, Weise K, Opitz N, Winter R (2012) The effect of Abeta on IAPP aggregation in the presence of an isolated beta-cell membrane. J\\ Mol Biol 421:348\u2013363. \n                    https:\/\/doi.org\/10.1016\/j.jmb.2012.01.048","journal-title":"J\\ Mol Biol"},{"key":"3414_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.230","author":"I Moreno-Gonzalez","year":"2017","unstructured":"Moreno-Gonzalez I et al (2017) Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/mp.2016.230","journal-title":"Mol Psychiatry"},{"key":"3414_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","volume":"5","author":"J Gotz","year":"2013","unstructured":"Gotz J, Lim YA, Eckert A (2013) Lessons from two prevalent amyloidoses-what amylin and Abeta have in common. Front Aging Neurosci 5:38. \n                    https:\/\/doi.org\/10.3389\/fnagi.2013.00038","journal-title":"Front Aging Neurosci"},{"key":"3414_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2001-0039","volume":"23","author":"JL Evans","year":"2002","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599\u2013622. \n                    https:\/\/doi.org\/10.1210\/er.2001-0039","journal-title":"Endocr Rev"},{"key":"3414_CR58","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler AE et al (2004) Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53:1509\u20131516","journal-title":"Diabetes"},{"key":"3414_CR59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A","volume":"60","author":"A Kapurniotu","year":"2001","unstructured":"Kapurniotu A (2001) Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Biopolymers 60:438\u2013459","journal-title":"Biopolymers"},{"key":"3414_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.tips.2013.12.005","volume":"35","author":"P Arosio","year":"2014","unstructured":"Arosio P, Vendruscolo M, Dobson CM, Knowles TP (2014) Chemical kinetics for drug discovery to combat protein aggregation diseases. Trends Pharmacol Sci 35:127\u2013135. \n                    https:\/\/doi.org\/10.1016\/j.tips.2013.12.005","journal-title":"Trends Pharmacol Sci"},{"key":"3414_CR61","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4593","volume":"14","author":"YS Eisele","year":"2015","unstructured":"Eisele YS et al (2015) Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov 14:759\u2013780. \n                    https:\/\/doi.org\/10.1038\/nrd4593","journal-title":"Nat Rev Drug Discov"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-018-3414-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3414-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3414-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T02:18:28Z","timestamp":1567477108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-018-3414-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1007\/s11010-018-3414-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}